Skip to main content
Home » Previous Episodes » Why ODs should investigate biologics for dry eye

Why ODs should investigate biologics for dry eye

C. Randall Harrell, MD, is founder, chairman, and CEO of Regenerative Processing Plant, the manufacturer of Regener-Eyes, a first-in-class biologic eye drop to treat dry eye.  Dr. Harrell joins Gary to discuss how biologics are used in dry eye and why ODs should get involved with them.

Find out:

  • Why biologics are necessary
  • Why MDs and ODs are slow to embrace them
  • Patient reaction to the concept of biologics
  • Why stem cells aren't involved

Listen to this episode to learn more about a new treatment option to help your dry eye patients.

Listen to the Show with iTunes

Listen to the Show without iTunes

Date: Wednesday, December 18, 2019

Leave a Reply

Your email address will not be published. Required fields are marked *